Nancy Hu’s Case Study on C. Auris Outbreak, Brooklyn, NY

Brooklyn, New York, experienced an outbreak of Candida auris (C. auris)—a multidrug-resistant fungal pathogen—in 2019. The fungus targets those with weakened immune systems, making it particularly deadly to those with comorbidities. C. auris infections can be difficult to treat, causing severe public health challenges globally.

Continue reading “Nancy Hu’s Case Study on C. Auris Outbreak, Brooklyn, NY”

Sarah Crisci’s Case Study on Candida auras in New York

Candida auras (C. auris) is a drug-resistant fungus with a dangerously high mortality rate. Most C. auris cases are resistant to one antifungal drug at minimum. However, chronic cases include strains which are resistant to all three antifungal drugs used to treat the fungus. Cases of C. auris typically arise in healthcare facilities, due to prolonged isolation periods following exposure.

Continue reading “Sarah Crisci’s Case Study on Candida auras in New York”

WHO Outlines Global Strategies to Tackle Antimicrobial Resistance Threat to Public Health

AMR is a leading cause in global fatalities from infectious diseases such as malaria and HIV. An international team of researchers studied what is known as “the most comprehensive assessment yet” for antimicrobial resistance (AMR) in humans.

Continue reading “WHO Outlines Global Strategies to Tackle Antimicrobial Resistance Threat to Public Health”

Antibiotic Resistance: Iraq’s Silent Post-War Enemy

Antibiotic resistance is regarded as a “silent tsunami”, as described by Emad Ahmad, a member of the Mosul General Hospital in Iraq. The hospital’s recent antibiograms (tables showing antimicrobial susceptibility) have presented evidence of increasing antibiotic resistance for an array of bacterial infections.

Continue reading “Antibiotic Resistance: Iraq’s Silent Post-War Enemy”